Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP169853.RAQVE_b7ZQVVzD5OUvcThcT2uOIjCMxuP1lNTDXYQZl8M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP169853.RAQVE_b7ZQVVzD5OUvcThcT2uOIjCMxuP1lNTDXYQZl8M130_assertion type Assertion NP169853.RAQVE_b7ZQVVzD5OUvcThcT2uOIjCMxuP1lNTDXYQZl8M130_head.
- NP169853.RAQVE_b7ZQVVzD5OUvcThcT2uOIjCMxuP1lNTDXYQZl8M130_assertion description "[Since DTctGMCSF enters and kills its target cells by unique mechanisms (GMCSF-receptor binding and protein synthesis inhibition) and is not similar in structure to Pgp or MRP substrates, we postulated that it would be an active agent against therapy-resistant AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP169853.RAQVE_b7ZQVVzD5OUvcThcT2uOIjCMxuP1lNTDXYQZl8M130_provenance.
- NP169853.RAQVE_b7ZQVVzD5OUvcThcT2uOIjCMxuP1lNTDXYQZl8M130_assertion evidence source_evidence_literature NP169853.RAQVE_b7ZQVVzD5OUvcThcT2uOIjCMxuP1lNTDXYQZl8M130_provenance.
- NP169853.RAQVE_b7ZQVVzD5OUvcThcT2uOIjCMxuP1lNTDXYQZl8M130_assertion SIO_000772 9168435 NP169853.RAQVE_b7ZQVVzD5OUvcThcT2uOIjCMxuP1lNTDXYQZl8M130_provenance.
- NP169853.RAQVE_b7ZQVVzD5OUvcThcT2uOIjCMxuP1lNTDXYQZl8M130_assertion wasDerivedFrom befree-20140225 NP169853.RAQVE_b7ZQVVzD5OUvcThcT2uOIjCMxuP1lNTDXYQZl8M130_provenance.
- NP169853.RAQVE_b7ZQVVzD5OUvcThcT2uOIjCMxuP1lNTDXYQZl8M130_assertion wasGeneratedBy ECO_0000203 NP169853.RAQVE_b7ZQVVzD5OUvcThcT2uOIjCMxuP1lNTDXYQZl8M130_provenance.